Form 4: Zimmer Biomet CFO Suketu Upadhyay Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Zimmer Biomet's CFO, Suketu Upadhyay, reported the vesting of restricted stock units and subsequent transactions involving common stock.

Summary

  • On March 6, 2024, Suketu Upadhyay, the Executive VP and CFO of Zimmer Biomet Holdings, Inc., reported transactions involving the company's common stock.
  • These transactions included the vesting of 4,561 restricted stock units (RSUs), each representing a contingent right to receive one share of Zimmer Biomet common stock.
  • One-third of the RSUs vested on March 6, 2024, with the remaining RSUs vesting in two equal installments on March 6, 2025, and March 6, 2026.
  • Upadhyay also disposed of 1,919 shares to satisfy tax withholding obligations at a price of $125.82 per share.
  • Following these transactions, Upadhyay directly owns 20,764 shares of Zimmer Biomet common stock and 9,119 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.

Future Outlook

The remaining RSUs will vest in two tranches on March 6, 2025, and March 6, 2026.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies like Zimmer Biomet. It provides transparency regarding the financial interests of key executives.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding executive compensation and stock ownership.

Key Dates

DateDescription
03/06/2024Date of earliest transaction, vesting of RSUs, and tax withholding.
03/06/2025Date of next RSU vesting (one-half).
03/06/2026Date of final RSU vesting (one-half).
03/07/2024Date of report filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.